Mersana Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Mersana Therapeutics, Inc. annual Depreciation history and growth rate from 2015 to 2023.
  • Mersana Therapeutics, Inc. annual Depreciation for 2023 was $1.5M, a 66.7% increase from 2022.
  • Mersana Therapeutics, Inc. annual Depreciation for 2022 was $900K, unchanged from 2021.
  • Mersana Therapeutics, Inc. annual Depreciation for 2021 was $900K, a 10% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.5M +$600K +66.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $900K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $900K -$100K -10% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1M -$245K -19.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.25M -$12K -0.96% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $1.26M +$329K +35.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $928K +$273K +41.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $655K +$358K +121% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 $297K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.